OKT3 THERAPY AS A CAUSE OF HIGH PANEL-REACTIVE ANTIBODIES IN SERUM USING STANDARD MICROCYTOTOXICITY TECHNIQUES

Publisher Website
Google Scholar
Abstract
No abstract available